Grupo de investigación de tumores del sistema nervioso central
SNC
Instituto Valenciano de Oncologia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (7)
2013
-
Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: Comparison between FISH and RT-PCR
BioMed Research International, Vol. 2013
2012
-
CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma
Clinical and Experimental Metastasis, Vol. 29, Núm. 6, pp. 625-637
-
Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production
Pathology and Oncology Research, Vol. 18, Núm. 4, pp. 793-802
2007
-
Concurrent EGFR amplification and TP-53 mutation in glioblastomas
Clinical Neuropathology, Vol. 26, Núm. 5, pp. 224-231
2006
2005
-
Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme
Clinical Neuropathology, Vol. 24, Núm. 5, pp. 209-218
2004
-
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)
Journal of Neuro-Oncology, Vol. 70, Núm. 3, pp. 359-370